Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion

Enhancing transdermal delivery of opioid antagonists and agonists using codrugs linked to bupropion or hydroxybupropion

US Patent 8653271 · Granted Feb 18, 2014

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cellulose based anti-viral anti-microbial spray coating2025
Vesicular monoamine transporter-2 ligands and their use in the treatment of psyc2024
Tempo-cellulose structures and related methods2024
Inhibitors of oxidized low-density lipoprotein receptor 1 and methods of use the2022
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2022
Dehydroleucodine derivatives and uses thereof2021
Vesicular monoamine transporter-2 ligands and their use in the treatment of psyc2020
DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, d2020
Triazole derivatives of melampomagnolide B and methods of use thereof2019
Use of parthenolide derivatives as antileukemic and cytotoxic agents2019
Abuse deterrent opioid/opioid-antagonist transdermal patch2019
Disubstituted triazole analogs2019